Rabies is a fatal disease caused by rabies virus, a neurotropic virus and a prototype of Lyssavirus of Rhabdoviridae family. It is transmitted to human beings through infected saliva of dogs and cats during bite. Dog is the cause of more than 90% of human rabies in India. The incubation period is 4-8 weeks (but it may vary from 5 days to 7 years). There are two clinical types of rabies -encephalitic (furious) and paralytic (dumb) types. In the encephalitic (furious) form, the principal malfunction is in the brain stem and limbic system. Patient has hydrophobia in the full-blown form, but the mind remains clear till the end. Death occurs within a week after the onset of symptoms. Paralytic rabies resembles Guillain-Barre syndrome. Diagnosis is mostly clinical. However, direct fluorescent antibody test is used to identify the antigen in skin biopsy from the nape of neck. In the postmortem specimen, demonstration of Negri bodies in the brain confirms the diagnosis. Anti-rabies vaccine is used for pre-and post-exposure prophylaxis. The commonly used intramuscular (IM) regimen is being superseded by intradermal (ID) vaccine because it makes the treatment economical. Whereas touching of animal or lick on intact skin does not require vaccination, any transdermal bite with bleeding requires immediate administration of rabies immunoglobulin (RIG) and simultaneous vaccination with a tissue culture vaccine (TCV). Minor abrasion without bleeding may require only vaccination and no RIG. Rabies human monoclonal antibody (RMAb) is the newest entry in the prophylaxis of rabies which may ultimately replace RIG. Prognosis is grave since there are just six reports of survivors. Treatment is mainly palliative with heavy sedation and/or therapeutic coma (Milwaukee protocol).
INTRODUCTION
Rabies is a fatal disease of nearly worldwide distribution that is caused by a fi lterable neurotropic virus present in the saliva of the infected animals and transmitted to humans through their infected saliva.
Urban rabies is propagated chiefly by unimmunized domestic or street dogs and cats. Street virus is the natural virus present in rabid animals. Wild-life or sylvatic-type rabies is propagated by wolves, foxes, skunks, jackals, etc., which are the main reservoirs and transmitters of rabies. [1] These animals maintain a cycle among them and transmit the disease to dogs and domestic animals. Humans may contract rabies by intrusion into the wild-life cycle of rabies. Bat rabies occurs in certain Latin American countries where the vampire bat serves as an important host and vector for rabies. In the USA, insectivorous bats and wild animals are the most important vectors at present.
The source of infection in humans is the saliva of rabid animals. Domestic dog is the cause of more than 90% of human rabies in India. Dogs also infect cats and other domestic species.
EPIDEMIOLOGY
The true incidence is unknown. In India, the estimated mortality is 25,000 to 50,000 deaths per year. Recent fi gures in China show less than 1000 cases per year. In Bangladesh, about 2000 deaths and in Nepal, about 200 deaths occur per year. Only 0.01% cases of human rabies occur in the temperate zones.
AETIOPATHOGENESIS
Rabies virus is the prototype of the genus Lyssavirus of the large family of Rhabdoviridae. It is a bullet-shaped virus containing a single-strand of ribonucleic acid (RNA) combined with nucleoprotein that forms a helical coil. The virus is rapidly inactivated by heat. At 56°C, the half-life is less than 1 min. The lipid coat is disrupted by 1% soap solution.
Humans are infected by inoculation of virus-laden saliva by the bite of a rabid dog or animal. Licking on abraded skin or mucus membrane may also result in infection. Scratching by claws can also cause infection. The virus cannot enter through intact skin.
The rabies virus travels in the nerves and is carried centripetally by the flow of axoplasm to the dorsal root ganglion. It multiplies further in the dorsal root ganglion and causes characteristic prodromal symptoms and paresthesias at the site of inoculation. From there it travels to the brain, where massive viral replication occurs. Then the virus migrates along the efferent nerves to almost every organ such as adrenal medulla, cornea, pancreas, nerve twiglet of the hair follicle, and salivary gland, and this leads to virus shedding in the saliva. Virus may also be shed in milk and urine.
At autopsy, widespread infection is usually found in the brain, particularly in the brainstem, hippocampus, and basal ganglia. Congestion of blood vessels of the central nervous system (CNS) and petechial hemorrhages of the pia-arachnoid are found. Histological examination shows perivascular cellular infi ltration of lymph spaces. Negri bodies can be detected within the cytoplasm of nerve cells as round or oval eosinophilic inclusion bodies, particularly in the hippocampus and Purkinje cells of the cerebellum. Negri bodies are also found in the brain of more than 95% of rabid animals. [1] 
CLINICAL FEATURES
Incubation period is usually 4-8 weeks, but may vary from 5 days to 7 years. Face, neck, and head bites which are close to the CNS have a shorter incubation period.
It may be of two types: • Encephalitic type (furious rabies) -observed in the majority of cases • Paralytic type (dumb rabies) -observed in about 20% of cases
Encephalitic type (furious rabies)
The onset is usually sudden. But prodromal symptoms are noted for 2-3 days before the hydrophobic syndrome appears. Only a proportion of people bitten by a rabid animal develop the disease, but once manifested, the disease is almost invariably fatal. Specifi c prodromal features include paresthesias and itching over the healed bite wound scar. Other features are fever, headache, tachycardia, anxiety, insomnia, restlessness, and myalgias. After 2-3 days, the stage of excitement supervenes. There is mental excitement, restlessness, hyperesthesia, and hydrophobia. Hyodrophobia consists of sudden spasm of muscles of the mouth, pharynx, larynx, and the whole of the respiratory musculature, particularly the diaphragm and muscles of inspiration. The attack can be induced by offering water to patients. As the glass of water approaches the mouth, typical spasmodic jerks with violent contraction of diaphragm and other inspiratory muscles occur and water is ejected from the mouth. Afterward, the sight and even the sound of water may provoke the distressing spasm. In the later stage, a wide number of stimuli like sudden sound, strong lights, and even the suggestion of water may induce the attack. Cold air or blowing of air due to fan may also induce an attack (aerophobia). The mind remains clear during the intervals. Hallucinations, delusions accompanied by biting, mania, and spitting may develop later. There is malfunction of brain stem, limbic system, and higher centers.
Death occurs within a week after the onset of symptoms.
Paralytic type (dumb rabies)
It characteristically occurs in bat-transmitted rabies. It also occurs in partially vaccinated persons. Patient presents with fl accid paralysis. It resembles Guillain-Barre syndrome. [2] The stage of excitement is absent. In a few days, paralysis may ascend to involve the respiratory muscles. There is fever and profuse sweating.
The patient has a comparatively longer survival.
DIAGNOSIS
Diagnosis is confi rmed by virus isolation, identifi cation of antigen, and detection of antibodies. [3] Virus culture is positive in the fi rst week from saliva, throat swab, eye swab, and cerebrospinal fl uid (CSF).
Antigen detection
Direct fl uorescent antibody test is used to identify the antigen in skin biopsies taken from the nape of the neck, where hair follicles are highly innervated. It is a sensitive test and positive results are found in 60-100% cases. The corneal smear test is not so sensitive and false-positive results occur.
Antibody detection
Seroconversion occurs during the second week of illness in unvaccinated patients. Antirabies antibody detection in serum and CSF confi rms the diagnosis.
Negri body detection
The offending animal is captured (if possible) and humanely killed for demonstration of Negri bodies in the brain. Fluorescent antigen can also be detected in the animal's brain, and confi rms the diagnosis of rabies. Milwaukee protocol [4] In September, a 15-year-old girl developed features of rabies 37 days after being bitten by a bat on her fi nger.
DIFFERENTIAL DIAGNOSIS
In an attempt to treat the patient, doctors placed her on induced coma and gave ketamine, midazolam, ribavarin, and amantadine. After 31 days of intensive care, the patient recovered, but had some neurological defi cits like inability to walk and maintain balance. She became the fi rst case of rabies who survived without being vaccinated.
This original Milwaukee protocol has undergone several modifi cations and out of 25 patients thus treated, only 2 have survived.
PROPHYLAXIS
Rabies vaccine can be used for pre-exposure prophylaxis (PrEP) as well as post-exposure prophylaxis (PEP).
The commonly used regimen of intramuscular (IM) administration (1 ml) of vaccine is being superseded by intradermal (ID) vaccination, which requires lesser quantity of vaccine (0.1 ml) and is equally effective. [5] Post-exposure prophylaxis PEP is begun immediately after an exposure. Before initiating anti-rabies treatment, one should establish the category of the animal bite [ Table 1 ]. This categorization helps in deciding the future course of action. [3] In addition, tetanus toxoid and proper antibiotics should be used.
PEP consists of a regimen of one dose of immunoglobulin (passive immunization) and fi ve doses of rabies vaccine over a period of 28 days. Vaccines should be given intramuscularly. Alternatively, vaccine can be given intradermally also. Human rabies immunoglobulin (RIG) should be infiltrated around the wound and any remaining portion should be administered intramuscularly, preferably in the gluteal region. Alternatively, equine immunoglobulin 40 IU/kg may a Exposure to rodents, rabbits, and hares seldom, if ever, requires specific anti-rabies post-exposure prophylaxis, b If an apparently healthy dog or cat in or from a low-risk area is placed under observation, the situation may warrant delaying initiation of treatment, c This observation period applies only to dogs and cats. Except in the case of threatened or endangered species, other domestic and wild animals suspected as rabid should be humanely killed and their tissues examined for the presence of rabies antigen using appropriate laboratory techniques, d Post-exposure prophylaxis should be considered when contact between a human and a bat has occurred unless the exposed person can rule out a bite or scratch or exposure to the mucus membrane be administered. Equine immunoglobulin is cheaper, but the incidence of serum reactions is more.
IM regimen
There are currently four types of vaccines available, and the regimen most commonly used in India for IM administration is described below: Human rabies immunoglobulin (20 IU/kg)
The sixth dose is optional and given to individuals who are immune defi cient. Day 0 indicates the date of fi rst injection.
Vaccines are ideally given in the deltoid region, and may be given in antero-lateral part of the thigh for children.
ID regimen
ID recommendation by WHO is a newer attempt to have effective antibody titers against rabies with a lower total requirement of vaccine. The principle that allows ID vaccination to be effective at a lower dose is that it may be due to the better response to an equal volume of antigen which is placed in contact with Langerhans cells of the epidermis and because of multiple sites of vaccination at the same time to obtain maximum drainage of antigenpresenting cells to the lymph nodes.
On the basis of the recommendations on ID administration of rabies vaccine by WHO and reports of safety, effi cacy, and feasibility trials conducted in India, the Drug Controller General of India (DCGI) approved the use of reduced dose ID vaccination in 2006.
The following vaccines are currently approved by DCGI for use by ID route: This involves injection of only 0.1 ml of reconstituted vaccine per ID site and the vaccination has to be given at two different sites on a single visit (one on each deltoid area, an inch above the insertion of deltoid muscle) on days 0, 3, 7, and 28, using a 1-ml insulin syringe. A bleb formed after injection is a sign of successful ID administration. It is best used in anti-rabies clinics for group vaccinations (for a minimum of 10 persons at a time) because the contents of a broken ampoule of 1 ml have to be used within 8 h and the requirement for a single person on a single visit will be just 0.2 ml and the rest will thus go waste.
ID vaccination is not indicated in patients with immunocompromised states or those on immunosuppressants like chloroquine or prednisolone. They should take full dose of IM injections.
Wound treatment
Wound treatment is the most important part of treatment and should begin immediately. It minimizes the viral load. Wound should be thoroughly cleaned with soap and water. Povidone iodine or 70% alcohol should be used to irrigate the wound. Suturing of the wound is to be avoided. Bites of rats, mice, rabbits, and guinea pigs do not require anti-rabies PEP.
Pre-exposure prophylaxis
PrEP is recommended for animal handlers and laboratory workers dealing with rabies virus. PrEP consists of three doses of rabies vaccine given either intramuscularly or intradermally on days 0, 7, and 21.
PROGNOSIS
The prognosis of rabies encephalomyelitis is grave. At the time of the bite, before the virus has invaded the nervous system, correct and prompt cleansing of the wound and proper post-exposure immunization reduce the risk of development of rabies from 50% to less than 5%. The risk is highest following head bites. Interposition of clothing, extent of tissue laceration, and immediate local treatment modify the prognosis.
RECENT ADVANCES
1. It has been now possible to achieve active immunization with four doses of tissue culture vaccine (instead of fi ve). [6] 2. Fully human monoclonal antibodies (mAbs) have been found to be safer and equally effi cacious than conventional RIG. [7, 8] Currently, only human and equine polyclonal anti-rabies immunoglobulin (HRIG and ERIG) are available. Replacement of HRIG and ERIG with a safer and more widely available product is recommended. Recently, a combination of two human MAbs, CR57 and CR4098, that has high potential has been identifi ed. A head-to-head comparison between CR57/CR4098 MAb cocktail and HRIG has been made. The MAb cocktail neutralized all viruses from a panel of 26 representative street rabies virus isolates. In combination with the vaccine, the MAb cocktail protected Syrian hamsters against lethal rabies when administered 24 h after exposure, comparable with the results obtained with HRIG. Furthermore, the MAb cocktail did not interfere with rabies vaccine differently from HRIG. These results demonstrated that the human MAb cocktail of CR57 and CR4098 is a safe and effi cacious alternative to RIG in rabies PEP. [9] In a phase 1 trial at the King Edward Memorial Hospital (KEM) in Mumbai, India, 74 healthy volunteers were randomized into several groups that either received rabies human monoclonal antibody (RMAb) or hRIG combined with vaccine. Results showed that the RMAb was well tolerated by all subjects, with no serious side effects. A dose of RMAb produced similar level of rabies virus neutralizing antibody in the blood from volunteers who received RMAb and vaccine as compared to those who received the standard regimen of hRIG and vaccine. Based on these data, Serum Institute of India has received approval to conduct the current trial. [10] 3. Sudarshan et al. have found more compliant "new 1 week ID regimen" equally effective as the conventional 4 week ID regimen. Patients in this trial received PCECV or PVRV at four sites on days 0, 3, and 7 (4-44). [11] 
